Korean and East Asian skin in Busan Seomyeon, and what actually differs.

Patients arriving from Western countries ask whether Korean expertise transfers to their skin, and patients of East Asian descent ask whether treatment developed elsewhere suits theirs. Both questions have the same answer once the actual differences are set out.

Difference one — a thicker dermis

East Asian skin has, on average, a thicker dermis with denser collagen than Northern European skin. That translates into slower visible wrinkling — lines appear later and shallower for the same age — and it is the main reason ageing presents differently. What it does not mean is slower ageing overall: laxity and volume loss proceed on the same schedule and become the dominant complaint instead of lines.

Difference two — more reactive melanocytes

The clinically important one. Melanocytes in higher Fitzpatrick types respond more strongly to inflammation, which is why post-inflammatory hyperpigmentation is the complication that shapes every laser protocol here. It is also why melasma is more prevalent and why energy settings across the board run lower than a Western textbook would suggest.

Difference three — higher sebaceous activity

Sebum output is higher on average, particularly through the central face, which produces the oily-and-congested presentation that makes microbotox more established here than elsewhere. Combined with a humid summer climate, that is why pore appearance is among the most common presenting concerns in Korea and a comparatively minor one in drier markets.

What follows clinically

Lower fluence, longer intervals and a test pass on anything pigment-related. A preference for picosecond platforms, since shorter pulses reduce heat diffusion. Melasma protocols built around control rather than clearance. And a treatment mix weighted toward lifting and volume rather than toward line reduction, because lines arrive later — see how lasers work.

If I am Caucasian, do these protocols suit me?

Largely yes, and with a caveat worth stating. Korean clinics see Fitzpatrick III to IV constantly and lighter types regularly, since foreign patients are a meaningful share of practice here. What is less familiar is Fitzpatrick I skin at the very light end, where higher energies are tolerated than local protocols habitually use — which usually means conservative treatment producing a slower result rather than any risk.

The reverse direction, which matters more

Less reliably, and this is the more consequential direction. Settings that clear a lentigo safely on Fitzpatrick II can provoke weeks of darkening on type IV, and a clinician treating higher types occasionally is working from a narrower base. This is the specific reason patients of East Asian descent living in Western countries frequently seek treatment here rather than at home.

Why is this framed around skin rather than nationality?

Because the variable that changes treatment is measurable and the category is not. Two patients described the same way ethnically can sit two Fitzpatrick types apart, and two patients from opposite sides of the world can respond identically. Protocols built around a passport rather than an assessment get both groups wrong — the light-skinned East Asian patient treated too cautiously and the darker-skinned European patient treated too aggressively. Asking what type you are, and being told a number rather than a reassurance, is what closes that gap — see clinic terms explained.

What does this mean for choosing where to be treated?

That the useful question is what the clinic sees regularly rather than where it is. A practice treating higher Fitzpatrick types daily has settings, intervals and test-pass habits built around them, which is a genuine advantage for anyone in that range regardless of where they live. The same logic works in reverse for very light skin. It also means the entire menu — botox, filler, lifting and boosters — is unaffected by this discussion, since only pigment-targeting treatment depends on it.

What is marketing rather than biology

Products described as formulated for Asian skin, which is a positioning claim rather than a formulation difference in most cases. Routines presented as Korean rather than as suited to a climate. And the implication that treatment developed in Korea is inherently gentler — settings are gentler for a specific reason, and the same device at the same settings behaves identically wherever it is used.

What is not a difference at all

The four layers of ageing, the collagen response curve, the mechanism of every device and injectable, and the way results should be judged. Biology does not vary by nationality. What varies is the parameters chosen within it, which is why the useful question is about your Fitzpatrick type rather than about your passport — see why faces age.

How this shapes a consultation here

Fitzpatrick type is assessed physically rather than inferred, and a history of marking after spots or scratches is asked about specifically since it predicts pigment response better than skin colour alone. Where a patient sits at either end of the range, settings are adjusted and a test pass used — see how a consultation works.